Drug intelligence / Profile preview

Lu AF95245

Development stage
Unknown
Lead developer
Lundbeck
Modality
Small Molecules
Administration
Oral
01

Overview

Lu AF95245 is a small molecule drug developed by H. Lundbeck for the treatment of central nervous system disorders. It acts as an agonist of potassium channels, specifically activating the Kv7.2–Kv7.5 (KCNQ2-5) subtypes, which are important in regulating neuronal excitability. The drug was investigated primarily for its potential use in neurological or psychiatric conditions but did not progress beyond early clinical development due to an unfavorable pharmacokinetic profile. Clinical trials included phase 1 studies assessing safety and tolerability in healthy volunteers. Development has since been discontinued.

02

Targets

KCNQ3 (Potassium voltage-gated channel subfamily Q member 3)KCNQ4 (Potassium channel subfamily KQT member 4)KCNQ2 (Potassium voltage-gated channel subfamily KQT member 2)KCNQ5 (Potassium voltage-gated channel subfamily KQT member 5)

Beyond the preview

Go deeper on Lu AF95245.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lu AF95245.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call